{"organizations": [], "uuid": "373850f370fda618423dc7e0d751d612a72b7411", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180504.html", "section_title": "Archive News &amp; Video for Friday, 04 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bone-therapeutics-q1-cash-balance/brief-bone-therapeutics-q1-cash-balance-of-10-42-million-euros-idUSFWN1SA1F2", "country": "US", "domain_rank": 408, "title": "BRIEF-Bone Therapeutics Q1 Cash Balance Of 10.42 Million Euros", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.945, "site_type": "news", "published": "2018-05-04T13:13:00.000+03:00", "replies_count": 0, "uuid": "373850f370fda618423dc7e0d751d612a72b7411"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bone-therapeutics-q1-cash-balance/brief-bone-therapeutics-q1-cash-balance-of-10-42-million-euros-idUSFWN1SA1F2", "ord_in_thread": 0, "title": "BRIEF-Bone Therapeutics Q1 Cash Balance Of 10.42 Million Euros", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 4 (Reuters) - BONE THERAPEUTICS SA:\n* APPOINTMENTS OF JEAN STÉPHENNE AS CHAIRMAN * CASH BURN FOR FULL YEAR OF 2018 IS EXPECTED TO BE IN RANGE OF EUR 15-16 MILLION\n* EXPECTS TO HAVE SUFFICIENT CASH TO CARRY OUT ITS OBJECTIVES UNTIL END Q3 2019\n* THE COMPANY ENDED THE FIRST QUARTER OF 2018 WITH A CASH BALANCE OF € 10.42 MILLION\n* PATIENT RECRUITMENT COMPLETED FOR THE PHASE IIA LUMBAR SPINAL FUSION STUDY WITH ALLOB\n* € 19.45 MILLION OF COMMITTED CAPITAL RAISED VIA PRIVATE PLACEMENT OF CONVERTIBLE BONDS\n* PLANS TO REPORT FINAL RESULTS FROM ALLOB PHASE I/IIA DELAYED-UNION STUDY IN MID-2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-04T13:13:00.000+03:00", "crawled": "2018-05-05T12:11:49.012+03:00", "highlightTitle": ""}